经导管主动脉瓣置换术后感染性心内膜炎合并卒中
该研究基于国际TAVR后感染性心内膜炎注册研究(569例),分析TAVR后确诊感染性心内膜炎患者住院期间卒中的发生率、危险因素及结局。结果显示10%患者发生卒中,既往卒中、TAVR后残余主动脉瓣反流≥中度、球囊扩张瓣膜、TAVR后30天内感染性心内膜炎、赘生物>8mm与卒中风险增高相关;卒中患者院内死亡率54.4% vs 28.7%,1年死亡率66.3% vs 45.6%,手术治疗未改善结局。
要点
- TAVR后感染性心内膜炎患者住院期间卒中发生率为10%。
- 卒中风险因素包括既往卒中、残余反流≥中度、球囊扩张瓣、早期感染性心内膜炎、赘生物>8mm。
- 卒中患者院内及1年死亡率显著增高,手术未改善结局。
核心结论
- TAVR后感染性心内膜炎患者中约1/10发生卒中,卒中与院内及1年死亡率增高相关,手术治疗未改善临床结局。
研究设计与样本
- 基于感染性心内膜炎后TAVR国际注册研究,纳入11个国家59个中心569例TAVR后确诊感染性心内膜炎患者,按住院期间是否发生卒中分为两组。
主要发现
- 57例(10%)患者住院期间发生卒中,两组致病微生物无差异。
- 卒中组急性肾衰竭、系统性栓塞和持续性菌血症发生率更高(p<0.05)。
- 卒中患者院内死亡率54.4% vs 28.7%(p<0.001),1年总死亡率66.3% vs 45.6%(p<0.001)。
- 无危险因素患者卒中发生率为3.1%,>3个危险因素时增至60%。
- 卒中患者中手术治疗未改善结局(院内死亡率46.2% vs 58.1%,p=0.47)。
关键数值与推荐
- 卒中风险因素:既往卒中、TAVR后残余主动脉瓣反流≥中度、球囊扩张瓣膜、TAVR后30天内感染性心内膜炎、赘生物>8mm(p<0.05)。
临床怎么用
- 对TAVR后感染性心内膜炎患者应评估卒中风险因素,尤其存在多个危险因素时。
- 发生卒中的患者预后差,需加强监护和治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke is one of the most common and potentially disabling complications of infective endocarditis (IE). However, scarce data exist about stroke complicating IE after transcatheter aortic valve replacement (TAVR). OBJECTIVES: The purpose of this study was to determine the incidence, risk factors, clinical characteristics, management, and outcomes of patients with definite IE after TAVR complicated by stroke during index IE hospitalization. METHODS: Data from the Infectious Endocarditis after TAVR International Registry (including 569 patients who developed definite IE following TAVR from 59 centers in 11 countries) was analyzed. Patients were divided into two groups according to stroke occurrence during IE admission (stroke [S-IE] vs. no stroke [NS-IE]). RESULTS: A total of 57 (10%) patients had a stroke during IE hospitalization, with no differences in causative microorganism between groups. S-IE patients exhibited higher rates of acute renal failure, systemic embolization, and persistent bacteremia (p < 0.05 for all). Previous stroke before IE, residual aortic regurgitation ≥moderate after TAVR, balloon-expandable valves, IE within 30 days after TAVR, and vegetation size >8 mm were associated with a higher risk of stroke during the index IE hospitalization (p < 0.05 for all). Stroke rate in patients with no risk factors was 3.1% and increased up to 60% in the presence of >3 risk factors. S-IE patients had higher rates of in-hospital mortality (54.4% vs. 28.7%; p < 0.001) and overall mortality at 1 year (66.3% vs. 45.6%; p < 0.001). Surgical treatment was not associated with improved outcomes in S-IE patients (in-hospital mortality: 46.2% in surgical vs. 58.1% in no surgical treatment; p = 0.47). CONCLUSIONS: Stroke occurred in 1 of 10 patients with IE post-TAVR. A history of stroke, short time between TAVR and IE, vegetation size, valve prosthesis type, and residual aortic regurgitation determined an increased risk. The occurrence of stroke was associated with increased in-hospital and 1-year mortality rates, and surgical treatment failed to improve clinical outcomes.
引用
- Del Val D, Abdel-Wahab M, Mangner N, et al. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2021. PMID: 33958124. doi:10.1016/j.jacc.2021.03.233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。